Rhonda L. Bohn

Validation of claims‐based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially‐insured population

Sebastian Schneeweiss, Norman Gitlin, Javed Butler, 2010, Pharmacoepidemiology and drug safety.

Validation of a claims‐based diagnostic code for Stevens–Johnson syndrome in a commercially insured population

P. Wahl, G. Daniel, Jay Levin, 2012, Pharmacoepidemiology and drug safety.

Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis

K. Rothman, P. Tennis, A. Zavras, 2012, Pharmacoepidemiology and drug safety.

A distributed research network model for post‐marketing safety studies: the Meningococcal Vaccine Study

Fang Zhang, Richard Platt, Priscilla Velentgas, 2008, Pharmacoepidemiology and drug safety.

Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination

R. Platt, S. Greenberg, C. Spettell, 2012, Pharmacoepidemiology and drug safety.

Early Steps in the Development of a Claims-Based Targeted Healthcare Safety Monitoring System and Application to Three Empirical Examples

J. Avorn, J. Rassen, J. Gagne, 2012, Drug Safety.

Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States

J. George, P. Wahl, B. Ewenstein, 2012, Transfusion.